Skip to content

Abstract TH216: A Multi-Omic Assessment of Gut Microbiome, Oral Microbiome, and Serum Metabolome Associations With Hypertension

Oct 2026 · HYPERTENSION · 0 citations

Abstract

Background: Gut and oral microbiota can influence host physiology through microbial metabolites, and both microbial and circulating metabolic signatures have been associated with hypertension. However, the relative strength of microbiome and metabolome associations with hypertension has not been evaluated within a single deeply phenotyped cohort. We compared gut microbiome, oral microbiome, and serum metabolomic profiles to characterize the molecular correlates of hypertension across multiple omic layers. Methods: Using the Human Phenotype Project, we defined hypertension by a curated phenotype integrating physician diagnosis, antihypertensive medication use, and measured office blood pressure (≥140/90 mmHg). For microbiome analyses, age-, sex-, and BMI-matched hypertensive and normotensive participants (988 pairs) underwent shotgun gut (388 species) and oral (84 species) metagenomic profiling. We assessed α-diversity, β-diversity, and differential abundance with covariate adjustment and false-discovery-rate correction. In parallel, we performed a metabolome-wide association study of 450 serum features (Nightingale NMR, lipidomics, and inflammatory markers) in 5,691 participants, including 961 with hypertension, adjusting for age, sex, BMI, and antihypertensive use. Results: Neither gut nor oral microbiome profiles showed a robust association with hypertension. Community structure was unchanged at both sites (α-diversity: gut P=0.33, oral P=0.83; β-diversity: R 2 <0.001, both P>0.1), and no microbial species remained significant after multiple-testing correction (0/388 gut, 0/84 oral at FDR<0.10). In contrast, the serum metabolome showed widespread associations with hypertension: 121 features reached FDR<0.10 (25 at FDR<0.05), of which 113 were elevated in hypertension. Significant associations were concentrated in lipoproteins (51 features), glycerolipids (34), phospholipids (11), and fatty acids (10), together with glucose. Phosphatidylcholine PC(32:1) was the strongest positive association (β=+0.33 SD, FDR=3х10 −4 ), whereas the polyunsaturated fatty-acid fraction was the strongest inverse association (β=–0.32 SD). Conclusions: Within a single deeply phenotyped cohort, hypertension was associated with a robust serum metabolomic signature but little reproducible association with gut or oral microbial taxonomic composition. The metabolomic signal was dominated by lipoprotein and glycerolipid measures. These findings suggest that hypertension-associated molecular variation may be captured more strongly in circulating metabolic profiles than in microbial community composition.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.